Literature DB >> 8794510

Serum cytokine concentrations in patients with schizophrenia.

I Baker1, J Masserano, R J Wyatt.   

Abstract

Interleukin-1 beta, interleukin-6, tumor necrosis factor-alpha and the soluble interleukin-2 receptor were measured in the serum of 34 healthy controls and 48 patients with chronic schizophrenia using ELISA sandwich assays. No differences were found between the controls and patients.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8794510     DOI： 10.1016/0920-9964(95)00089-5

Source DB:  PubMed          Journal:  Schizophr Res        ISSN： 0920-9964            Impact factor:   4.939


  10 in total

1.  Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects.

Authors:  Brian J Miller; Peter Buckley; Wesley Seabolt; Andrew Mellor; Brian Kirkpatrick
Journal:  Biol Psychiatry       Date:  2011-06-08       Impact factor: 13.382

2.  Inflammation in Schizophrenia: Cytokine Levels and Their Relationships to Demographic and Clinical Variables.

Authors:  Ellen E Lee; Suzi Hong; Averria Sirkin Martin; Lisa T Eyler; Dilip V Jeste
Journal:  Am J Geriatr Psychiatry       Date:  2016-10-17       Impact factor: 4.105

3.  Lower serum cytokine levels in smokers than nonsmokers with chronic schizophrenia on long-term treatment with antipsychotics.

Authors:  Xiang Yang Zhang; Lian Yuan Cao; Cai Song; Gui Ying Wu; Da Chun Chen; Ling Yan Qi; Fan Wang; Mei Hong Xiu; Song Chen; Yingyang Zhang; Lin Lu; Therese A Kosten; Thomas R Kosten
Journal:  Psychopharmacology (Berl)       Date:  2008-08-22       Impact factor: 4.530

Review 4.  [Cytokine network in patients with schizophrenia and its significance for the pathophysiology of the illness].

Authors:  A Schuld; D Hinze-Selch; Th Pollmächer
Journal:  Nervenarzt       Date:  2004-03       Impact factor: 1.214

Review 5.  Evidence for a dysregulated immune system in the etiology of psychiatric disorders.

Authors:  Sinead M Gibney; Hemmo A Drexhage
Journal:  J Neuroimmune Pharmacol       Date:  2013-05-05       Impact factor: 4.147

6.  Possible association between interleukin-1β gene and schizophrenia in a Japanese population.

Authors:  Daimei Sasayama; Hiroaki Hori; Toshiya Teraishi; Kotaro Hattori; Miho Ota; Yoshimi Iijima; Masahiko Tatsumi; Teruhiko Higuchi; Naoji Amano; Hiroshi Kunugi
Journal:  Behav Brain Funct       Date:  2011-08-16       Impact factor: 3.759

7.  Serum IL-1beta, sIL-2R, IL-6, IL-8 and TNF-alpha in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment.

Authors:  A B Erbağci; H Herken; O Köylüoglu; N Yilmaz; M Tarakçioglu
Journal:  Mediators Inflamm       Date:  2001-06       Impact factor: 4.711

Review 8.  Interleukin-6 in Schizophrenia-Is There a Therapeutic Relevance?

Authors:  Milica Milovan Borovcanin; Ivan Jovanovic; Gordana Radosavljevic; Jelena Pantic; Slavica Minic Janicijevic; Nebojsa Arsenijevic; Miodrag L Lukic
Journal:  Front Psychiatry       Date:  2017-11-06       Impact factor: 4.157

9.  Increased serum interleukin-1beta and interleukin-6 in elderly, chronic schizophrenic patients on stable antipsychotic medication.

Authors:  Andrea Schmitt; Thomas Bertsch; Heike Tost; Andrea Bergmann; Uwe Henning; Ansgar Klimke; Peter Falkai
Journal:  Neuropsychiatr Dis Treat       Date:  2005-06       Impact factor: 2.570

10.  Peripheral Biomarkers for First-Episode Psychosis-Opportunities from the Neuroinflammatory Hypothesis of Schizophrenia.

Authors:  Nuno Trovão; Joana Prata; Orlando VonDoellinger; Susana Santos; Mário Barbosa; Rui Coelho
Journal:  Psychiatry Investig       Date:  2019-03-07       Impact factor: 2.505
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.